Hyperlipidemias: Clinical Trials

22 trials for Hyperlipidemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 unknown. 22 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 322Unknown 22
Phase 28Unknown 8

Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
Phytoestrogen, Diet control & life style modification - Dyslipidemias, Hypertriglyceridemia
Phase 2 / Phase 3UnknownDhurakij Pundit University102024-03-022024-05-24
Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
Xian-Hua-Cha - Hyperlipidemias, Obesity
Phase 3UnknownChang Gung Memorial Hospital1002022-12-132024-10-08
Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose, Atorvastatin (Lipitor ®) - Dyslipidemia Associated With Type II Diabetes Mellitus
Phase 3UnknownLaboratorios Silanes S.A. de C.V.782022-02-152022-03-02
Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction
lerodalcibep, Placebo - Cardiovascular Risk Factor, Cardiovascular Diseases
Phase 3UnknownLIB Therapeutics LLC9002021-04-222023-12-11
Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia
IBI306 - Familial Hypercholesterolemia - Homozygous, Lipid Metabolism Disorders
Phase 2 / Phase 3UnknownShenzhen People's Hospital82019-11-052021-07-01
Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins
TED + glucose - Hyperlipidemias
Phase 2 / Phase 3UnknownUniversity Health Network, Toronto152019-05-012021-04-29
Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
Amlodipine 10mg+Valsartan 160mg+Atorvastatin 40mg, Amlodipine 10mg+Valsartan 160mg, Valsartan 160mg+Atorvastatin 40mg - Hypertension, Hyperlipidemia
Phase 3UnknownHK inno.N Corporation1802017-10-132018-08-21
A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
Rosuvastatin, Atorvastatin - Hyperlipidemia
Phase 2 / Phase 3UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh902016-09-012016-12-02
Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides
Omega-3-Acid Ethyl Esters 90 Soft Capsules, Corn Oil - Hypertriglyceridemia
Phase 3UnknownJiangsu HengRui Medicine Co., Ltd.2402015-12-012015-12-09
Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD
HCP1105, HGP0816, Placebo of HCP1105 - Hyperlipidemias
Phase 3UnknownHanmi Pharmaceutical Company Limited2702014-10-012015-09-16
The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients
Rosuvastatin/Ezetimibe - Hypercholesterolemia
Phase 3UnknownIlDong Pharmaceutical Co Ltd4002014-07-012014-09-29
Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
Atorvastatin 20mg, Omega-3-acids ethylesters 90 4g, Placebo(Omega-3-acids ethylesters 90) - Hyperlipidemia, Familial Combined
Phase 3UnknownKuhnil Pharmaceutical Co., Ltd.802014-01-012014-03-20
Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Atorvastatin 20mg, Fenofibrate 160mg, Placebo (Fenofibrate 160 mg) - Mixed Hyperlipidemia
Phase 3UnknownChong Kun Dang Pharmaceutical4762013-12-012015-02-04
Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
Telmisartan 80mg, Rosuvastatin 20mg, Rosuvastatin 10mg - Hypertension, Hyperlipidemia
Phase 3UnknownIlDong Pharmaceutical Co Ltd3102013-05-012014-03-14
Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids
Kochujang Pills, Placebo - Hyperlipidemia
Phase 2 / Phase 3UnknownChonbuk National University Hospital602012-11-012012-11-29
The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides
EGCG(Epigallocatechin Gallate), Placebo - Diabetes Mellitus, Hyperlipidemia
Phase 2 / Phase 3UnknownTaipei City Hospital922012-05-012014-05-26
The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia
Coenzyme A, Placebo - Hyperlipoproteinemia
Phase 2 / Phase 3UnknownZhejiang University3202012-03-012013-08-23
Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
Pitavastatin, Atorvastatin - Hyperlipidemia
Phase 3UnknownTai Tien Pharmaceuticals Co., Ltd.2002011-07-012011-07-01
Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia
AKR-963 - Severe Hypertriglyceridemia
Phase 3UnknownTrygg Pharma, Inc.2402010-10-012011-11-24
The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker
Niacin\Laropiprant - Hypercholesterolemia
Phase 3UnknownRambam Health Care Campus302010-04-012010-03-01

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Hypercholesterolemia (4)  ·  Hypertriglyceridemia (4)  ·  Dyslipidemias (2)  ·  Hypertension (2)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Homozygous Familial Hypercholesterolemia (1)  ·  Hyperlipidemia, Familial Combined (1)  ·  Hyperlipoproteinemia Type I (1)  ·  Hyperlipoproteinemia Type II (1)  ·  Hyperlipoproteinemias (1)  ·  Lipid Metabolism Disorders (1)  ·  Myocardial Infarction (1)

Broader conditions

Metabolic Diseases (22)  ·  Nutritional and Metabolic Diseases (22)  ·  Lipid Metabolism Disorders (21)  ·  Dyslipidemias (20)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Lipid Metabolism, Inborn Errors (4)  ·  Metabolism, Inborn Errors (4)  ·  Hyperlipoproteinemias (3)  ·  Vascular Diseases (3)  ·  Cardiovascular Diseases (2)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Atorvastatin (6)  ·  Rosuvastatin Calcium (3)  ·  Fenofibrate (2)  ·  Alipogene tiparvovec (1)  ·  Amlodipine (1)  ·  Cellulose (1)  ·  Coenzyme A (1)  ·  Corn Oil (1)  ·  Cyclosporine (1)  ·  Ezetimibe (1)  ·  Glucose (1)  ·  Mycophenolic Acid (1)  ·  Phytoestrogens (1)  ·  Tea (1)  ·  Telmisartan (1)

Sponsors

IlDong Pharmaceutical Co Ltd (2)  ·  Amsterdam Molecular Therapeutics (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Chang Gung Memorial Hospital (1)  ·  China Medical University Hospital (1)  ·  Chonbuk National University Hospital (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  Dhurakij Pundit University (1)  ·  HK inno.N Corporation (1)  ·  Hanmi Pharmaceutical Company Limited (1)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)  ·  Kuhnil Pharmaceutical Co., Ltd. (1)  ·  LIB Therapeutics LLC (1)  ·  Laboratorios Silanes S.A. de C.V. (1)  ·  Rambam Health Care Campus (1)

Countries

South Korea (7)  ·  Taiwan (4)  ·  Canada (2)  ·  China (2)  ·  Israel (2)  ·  United States (2)  ·  Bangladesh (1)  ·  India (1)  ·  Mexico (1)  ·  Thailand (1)

Top investigators

Chia-I Tsai, V.S (1)  ·  Chung-Hua Hsu, PHD (1)  ·  Duk-Hyun Kang, Ph.D (1)  ·  Evan A Stein, MD PhD (1)  ·  Francisco G Padilla Padilla, M.D (1)  ·  Hee Kyoung Cheon, Ph.D. (1)  ·  Hong Seog Seo, Ph.D. (1)  ·  Jaw-Wen Chen, M.D. Ph.D. (1)  ·  Juan A Peraza Zaldivar, M.D (1)  ·  Jung-yeol Park, M.D., Ph.D. (1)  ·  Junzhu Chen (1)  ·  Kevin C Maki, PhD (1)  ·  Liz Phima (1)

Results publications

PMID 18468736, PMID 22717743, PMID 24098467, PMID 24382338, PMID 25027585, PMID 26093535, PMID 38958989, PMID 40323331